Completed NA INTERVENTIONAL 1-arm NCT02168322

Perforated Barrier Membranes Maintain Physiologic Gingival Crevicular Fluid Growth Factor Levels

Perforated Barrier Membranes Maintain Physiologic Gingival Crevicular Fluid Growth Factor Levels During Treatment of Intrabony Defects: An In Vivo Proof-of-Principle Study

Sponsor: Al-Azhar University

Conditions Membrane Alteration Vascular Endothelial Growth Factor Overexpression

Interventions collagen membrane

Updated 5 times since 2017 Last updated: May 6, 2015 Started: Oct 31, 2013 Primary completion: Jan 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Membrane Alteration and Vascular Endothelial Growth Factor Overexpression and is currently completed. Al-Azhar University leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Al-Azhar University

Data source: Al-Azhar University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt